mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
SGX-523 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.4 |